Article
IConMHC: a deep learning convolutional neural network model to predict peptide and MHC-I binding affinity.
Immunogenetics - 1 Jul 2020
Pei Baikang, Hsu Yi-Hsiang
Abstract excerpt
Tumor-specific neoantigens are mutated self-peptides presented by tumor cell major histocompatibility complex (MHC) molecules and are necessary to elicit host's anti-cancer cytotoxic T cell responses. It could be specifically recognized by neoantigen-specific T cell receptors (TCRs). However, current wet-lab assays for identifying peptide MHC binding are too expensive and time-consuming to meet the clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
